Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
Applied Therapeutics, Inc. has filed 529 SEC EDGAR filings since 08 Feb 2017

SEC filing history

Showing 76-100 of 529 matching filings.

Per page
25
Current page
4
4

4

Filing date
26 Mar 2025
Reporting date
24 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
26 Mar 2025
Reporting date
24 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
06 Mar 2025
Reporting date
04 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
06 Mar 2025
Reporting date
04 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
06 Mar 2025
Reporting date
04 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-91017

SCHEDULE 13G/A filing

Filing date
14 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-91017

SCHEDULE 13G filing

Filing date
14 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-91017

SCHEDULE 13G filing

Filing date
14 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-91017

SCHEDULE 13G/A filing

Filing date
14 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-91017

SCHEDULE 13G filing

Filing date
14 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-91017

SCHEDULE 13G/A filing

Filing date
14 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
07 Feb 2025
Reporting date
06 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
07 Feb 2025
Reporting date
06 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
07 Feb 2025
Reporting date
06 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-91017

SCHEDULE 13G/A filing

Filing date
07 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-91017

SCHEDULE 13G/A filing

Filing date
05 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-91017

SCHEDULE 13G/A filing

Filing date
03 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-91017

SCHEDULE 13G/A filing

Filing date
27 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 Dec 2024
Reporting date
19 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 Dec 2024
Reporting date
19 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
20 Dec 2024
Reporting date
19 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-91017

SCHEDULE 13G/A filing

Filing date
06 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .